Synthetic proteasome-activating peptide 1 (PAP-1) increased the ChT-L activity of the 20S and prevented the aggregation of superoxide dismutase 1 (SOD1) in a cellular model of amyotrophic lateral sclerosis [24]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.